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ABSTRACT 
 
Researching and developing chemosynthetical drugs is the primary work of this 
thesis, including: a. primary research of antidiabetic and antihypertensive drugs target 
by PPAR; b. synthesis and industrialized improve of (1’R,3S,4S)-4-(Cyclo- 
propylcarbonyloxy)-3-(1-hydroxyethyl)azetidin-2-one which is the key intermedate in 
carbapenem antibiotics; c. synthesis and industrialized improve of 5-hydroxymethyl 
thiazole which is the key intermedate in Ritonavir, an anti-AIDS agent. 
1. Primary research of antidiabetic and antihypertensive drugs target 
by PPAR 
We designed a compoundⅠby refer to relative literature, and wish it would active 
PPAR, so that obtain double efficacies of antidiabetes mellitus and antihypertension. 
We also designed a simple synthesis route from hydroquinon, and synthesized 
compoundⅠby six steps reaction (10.1% yield). 
2. Synthesis and industrialized improve of 1’R,3S,4S-4-(cyclopropyl 
carbonyloxy)-3-(1-hydroxyethyl)azetidin-2-one 
We synthesized compoundⅡfrom L-threonine and cyclopropyl methyl ketone as 
raw materials, subsequently through eight steps including diazotization, epoxyazation, 
bromosubstitution, aminoalkylation, carboxamidation, deprotection and so on. The 
yield is 19.9 % purified by column chromatography on silica gel and 6.0 % purified 
by distillation under reduced pressure and crystallization. The characteristics of this 
synthesis route are easy to gain materials, simple to manipulate, so we reckon it has 
potential industrialized production. 
   We designed another synthesis route through allyl as amino-protection group.  
From L-threonine and cyclopropyl methyl ketone as raw materials, subsequently 
through nine steps we synthesized compoundⅤ(6.0 % yield). 














 - IV -  
Referring to relative literature, we validated three synthesis routes to synthesize 
5-hydroxymethylthiazoleⅥ with formamide, thiourea and 1,3-dichloro-1-propene as 
raw materials respectively. The experiment proved the synthesis route using thiourea 
as raw material gained the best yield (yield: 23.8%). We improved purification 
manipulation of this synthesis route, decreasing of purification manipulation, so that 
continuous reaction to ethyl thiazole-5-carboxylate directly. Furthermore, we 
optimized the condition of reductive system with KBH4/LiCl, and obtained 54% yield 























































Ac acetyl / 乙酰基 
Ans p-methoxyphenyl / 对甲氧基苯基 
Bn benzyl / 苄基 
BINAP 1.1'-binaphthyl-2.2'-diphemyl phosphine  
m-CPBA m-chloroperoxylbenzoic acid / 间氯过氧苯甲酸 
CAN cerium(IV) ammonium nitrate / 硝酸铈铵 
CHPA isopropylcyclohexylamine / 异丙基环己基胺 
DAM bis(4-methoxyphenyl)methyl /  二对甲氧苯基甲基 
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene/ 1,8- 二 氮 杂 双 环[5.4.0]十一碳-7-烯 
DEAD diethyl azodicarboxylate / 偶氮二甲酸二乙酯 
DMAP 4-N, N-dimethylaminopyridine / 4-N, N-二甲胺基吡啶 
DMB 2,4-dimethoxybenzy / 2,4-二甲氧基苯基 
EEDQ 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline 
HMDS hexmethyldisilazane / 六甲基二硅基胺烷 
LCHPA lithium cyclohexyl isopropylamide/环己基异丙基胺基锂 
LDA lithium isopropylamide / 二异丙基胺基锂 
NBS N-bromosuccinimide / N-溴代琥珀酰亚胺 
Ph phenyl / 苯基 
PG protective group / 保护基 
PTSA (p-TsOH) p-toluenesulfonic acid / 对甲苯磺酸 
Py (pyr) pyridine / 吡啶 















 - VI -  
 
TBDMS-OTf t-butyldimethylsilyl triflate/三氟甲磺酸叔丁二甲硅酯 
TBAB tetrabutylammonium bromide / 四丁基溴化铵 
TBAF tetrabutylammonium fluoride / 四丁基氟化铵 
Tf trifluoromethane sulfonate / 三氟甲磺酰基 
TFA trifluoroacetic acid / 三氟乙酸 
THF tetrahydrofuran / 四氢呋喃 
TMS trimethylsilyl / 三甲基硅基 
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第一章 前     言 
 
制药工业作为关系国民生命健康的一个行业，其重要性不言而喻。据统计，
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PPARγ受体具有部分激动的作用，而高剂量的伊贝沙坦对 PPARγ受体也有少量
的激活作用 4-5。某些以 PPAR 为作用靶点的糖尿病药物也具有降血压的作用，
如：罗格列酮等噻唑烷二酮类药物 6-7，苯扎贝特等 8-10 贝特类药物。 
因此，考虑开发一类以 PPAR 为作用靶点的既能降血糖，又能降血压的药物。










Scheme 1. 1 
 
 





成抗生素。其中，β-内酰胺类抗生素(β-lactam antibiotics)11-13 是 重要的一类抗
生素。 
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